Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Insulin Resistance × Pioglitazone × Clear all

Phase

Phase 4 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Insulin Resistance 1 Diabetes Mellitus, Type 2 1

Interventions

Metformin 5 lime 1 cinnulin PF 1 Resistance Training 1 Pioglitazone 1 Liraglutide 1 Exercise 1 Diet Therapy 1 DLBS3233 1 Contraceptives, Oral 1 Clomiphene 1 Caloric Restriction 1 Biguanides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05098327 2023-08-15

Pioglitazone and Insulin Resistance in ADT

State University of New York at Buffalo

Phase 3 Withdrawn

Diabetes Mellitus, Type 2, Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡